Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PaQ Insulin Delivery in T2DM
NCT02419859Completed
- Sponsor
- CeQur
- Start
- Feb 2015
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CeQur. Primary endpoint: Glycosylated hemoglobin A1C at 12 weeks. Started Feb 2015; status: completed.
Beyond the preview
Go deeper on NCT02419859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02419859.